Shares of clinical-stage biopharmaceutical company TC BioPharm Plc TCBP are continuing to trade higher Wednesday after the company on Tuesday announced a strategic collaboration to advance gamma-delta ...

The company will begin investigating the effectiveness of TCP008 for the highly infectious disease. During the COVID-19 pandemic, the world learned the importance of being ready for outbreaks. While ...

Shenzhen, China--(Newsfile Corp. - May 26, 2023) - Kexing Biopharm, a leading pharmaceutical company, has successfully concluded its participation at the renowned Kazakhstan International Healthcare ...

(RTTNews) - TC BioPharm (TCBP), a clinical-stage biotechnology company, on Thursday announced the successful completion of dosing for Cohort A in the ACHIEVE Phase 2B UK clinical trial. The trial ...

Shenzhen, China--(Newsfile Corp. - May 9, 2024) - Kexing Biopharm recently took an important step forward in cancer therapy. Kexing Biopharm signed a cooperation agreement with Kerui Pharma, a ...

BOSTON--(BUSINESS WIRE)--Infinata today announced the latest release of BioPharm Clinical, the leading tool to expedite study feasibility and clinical operations. This release features a completely ...

XuanZhu BioPharm and Chemical.AI announce collaboration focusing on cancer, metabolism, digestion and other fields, jointly to develop new drugs with proprietary intellectual property rights. Back in ...

Samyang Biopharm, a medical devices and biopharmaceutical affiliate of Samyang Group, soared on the Kospi on Monday as it made its debut on Korea’s main bourse after a spin-off from Samyang Holdings.

MIAMI--(BUSINESS WIRE)--Increased scrutiny and regulation in the nutraceutical and supplement market should be welcomed according to BioPharm CEO, Rafael Olartecoechea, producer of Vimulti® ...

TC BioPharm shares are trading lower by 44% Wednesday morning. The company announced the pricing of an offering of 2 million units at $1 per unit. Get Discounted Real-Time Trade Alerts For a Volatile ...